Related Experiment Video
Updated: May 12, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Non-adherence to therapy in type 2 diabetes]
1EA 3412, UFR-SMBH, CRNH-IdF, AP-HP, hôpital Avicenne, université Paris 13, service d'endocrinologie, diabétologie, maladies métaboliques, 93000 Bobigny, France. gerard.reach@avc.aphp.fr
Patient non-adherence to treatment, especially in type 2 diabetes, impacts care efficiency and costs. Improving adherence requires ethical considerations due to present-focused preferences versus long-term health goals.
Area of Science:
- Medical science
- Public health
- Behavioral science
Related Concept Videos
Type II Diabetes II: Pathophysiology
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis